Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs

BACKGROUND: Non-specific immunotherapeutics have been evaluated previously in dogs, primarily for cancer treatment. However, there remains a need for a more broadly targeted, general purpose immunotherapeutic capable of activating innate immune defenses for non-specific protection or early treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheat, William, Chow, Lyndah, Kuzmik, Alana, Soontararak, Sirikul, Kurihara, Jade, Lappin, Michael, Dow, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743184/
https://www.ncbi.nlm.nih.gov/pubmed/31519215
http://dx.doi.org/10.1186/s12917-019-2073-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743184/
https://www.ncbi.nlm.nih.gov/pubmed/31519215
http://dx.doi.org/10.1186/s12917-019-2073-8

Ejemplares similares